Exor Capital LLP Teva Pharmaceutical Industries LTD Transaction History

Exor Capital LLP

$3.23 Billion
Q3 2024

A detailed history of Exor Capital LLP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Exor Capital LLP holds 26,503,526 shares of TEVA stock, worth $451 Million. This represents 14.79% of its overall portfolio holdings.

Number of Shares

26,503,526

Previous 26,462,600 0.15%

Holding current value

$451 Million

Previous $430 Million 11.06%

% of portfolio

14.79%

Previous 15.49%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.81 - $18.96 $647,040 - $775,956	40,926 Added 0.15%	26,503,526 $478 Million
Q2 2024 Aug 12, 2024	BUY	$12.78 - $17.4 $486,470 - $662,331	38,065 Added 0.14%	26,462,600 $430 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $85.7 Million - $116 Million	-8,033,121 Reduced 23.31%	26,424,535 $373 Million
Q4 2023 Feb 13, 2024	BUY	$8.12 - $10.63 $4.94 Million - $6.46 Million	607,800 Added 1.8%	34,457,656 $360 Million
Q3 2023 Nov 13, 2023	BUY	$7.48 - $10.7 $72.1 Million - $103 Million	9,636,595 Added 39.8%	33,849,856 $345 Million
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $51.3 Million - $67.4 Million	7,121,351 Added 41.67%	24,213,261 $182 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $17.4 Million - $23.7 Million	2,083,521 Added 13.88%	17,091,910 $151 Million
Q3 2022 Nov 07, 2022	BUY	$6.86 - $11.95 $79 Million - $138 Million	11,522,187 New	11,522,187 $93 Million
Q4 2021 Feb 14, 2023	BUY	$7.9 - $10.19 $27.5 Million - $35.5 Million	3,486,202 Added 30.26%	15,008,389 $120 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exor Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Exor Capital LLP with notifications on news.

Account